Restrictions on Use or Disclosure. Covered Entity shall notify Business Associate of any restriction to the use or disclosure of Protected Health Information that Covered Entity has agreed to in accordance with 45 C.F.R. § 164.522, to the extent that such restriction may affect Business Associate’s use or disclosure of Protected Health Information.
Restrictions on Use or Disclosure. Covered Entity shall only disclose PHI to Business Associate or to others, pursuant to this BAA, in a manner and to an extent permitted by HIPAA. Covered Entity shall provide Business Associate with any changes in, or revocation of, permission by individuals to use and/or disclose PHI, to the extent such changes or revocations may affect Business Associate's permitted or required uses and/or disclosures of PHI. Further:
(i) Covered Entity shall notify Business Associate of any restriction to the use and/or disclosure of PHI that Covered Entity has agreed to in accordance with 45 CFR § 164.522, to the extent such restriction may affect Business Associate's permitted or required uses and/or disclosures of PHI;
(j) Covered Entity shall not request Business Associate use or disclose PHI in any manner that would violate the Privacy Rule if done by Covered Entity; and
Restrictions on Use or Disclosure. Within fifteen (15) business days of a request of the Provider, Boston Scientific agrees to implement restrictions on the use or disclosure of PHI agreed to by the Provider at the request of an Individual in accordance with 45 CFR § 164.522.
Restrictions on Use or Disclosure. Covered Entity shall only disclose PHI to Business Associate or to others, pursuant to this BA Agreement, in a manner and to an extent permitted by HIPAA. Covered Entity shall provide Business Associate with any changes in, or revocation of, permission by individuals to use and/or disclose PHI, to the extent such changes or revocations may affect Business Associate's permitted or required uses and/or disclosures of PHI. Further, Covered Entity shall notify Business Associate of any restriction to the use and/or disclosure of PHI that Covered Entity has agreed to in accordance with 45 CFR § 164.522, to the extent such restriction may affect Business Associate's permitted or required uses and/or disclosures of PHI.
Restrictions on Use or Disclosure. Covered Entity shall notify Business Associate of any restriction to the use or disclosure of PHI that Covered Entity has agreed to in accordance with 45 C.F.R. § 164.522, to the extent that such restriction may affect Business Associate’s use or disclosure of PHI.
Restrictions on Use or Disclosure. Within fifteen (15) business days of a request of the Provider, HealthSnap agrees to implement restrictions on the use or disclosure of PHI agreed to by the Provider at the request of an Individual in accordance with 45 CFR § 164.522.
Restrictions on Use or Disclosure. Covered Entity shall notify Business Associate of any restriction to the use or disclosure of PHI that Covered Entity has agreed to in accordance with 45 CFR § 164.522. Effective February 17, 2010, notwithstanding the paragraph (a)(1)(ii) of 45 CFR 164.522, the Business Associate must comply with the requested restriction if (1) except as otherwise required by law, the disclosure is to a health plan for purposes of carrying out payment or health care operations (and is not for purposes of carrying out treatment); and (2) the protected health information pertains solely to a health care item or service for which the health care provider involved has been paid out of pocket in full.
Restrictions on Use or Disclosure. Within fifteen (15) business days of a request of Plan, ESI agrees to consider restrictions on the use or disclosure of PHI agreed to by Plan on behalf of an Individual in accordance with 45 C.F.R. § 164.522.
Restrictions on Use or Disclosure. The parties agree that they will not use or disclose any confidential information that they receive except as is reasonably necessary for the purposes of this agreement.
Restrictions on Use or Disclosure. If an Individual or the Individual’s designee makes a request to ESI, or to a Subcontractor of ESI, for a restriction on the use and/or disclosure of the Individual’s PHI, or if the Individual’s restriction request is made to Plan and transmitted by Plan to ESI, then within ten (10) business days of a request of Plan, ESI shall consider restrictions on the use or disclosure of PHI and respond to a request for a restriction on the use or disclosure of the Individual’s PHI in accordance with 45 CFR § 164.522(a), and take other measures as necessary to satisfy Plan’s obligations under 45 CFR § 164.522(a).
